Daily Journal

Jul 20, 2026: Advanced Biomed led a +$284 day

By James · Monday, Jul 20, 2026 · ~2 min read
#ADVB #SHPH #SKHU #greenday #leveraged #journal
+$284 realized today · running day-trade P&L below

Green day. I ran my usual pre-market playbook — small, cheap names that pop on the open — and for once the exits lined up with the entries.

Catching ADVB

I worked ADVB (Advanced Biomed), in around $6.40 and out around $6.71 across 2 prints on 1,000 shares, for a +$315 win.

Nothing heroic here, and that's the point. Take the move, book it, move on.

SHPH: where it went wrong

I worked SHPH (Shuttle Pharmaceuticals), in around $3.62 and out around $3.53 across 22 prints on 1,000 shares, for a -$87 hit.

SKHU did the work

I worked SKHU (ProShares Ultra SK Hynix) — the 2x leveraged fund that tracks SK Hynix. I was in around $17.98 and out around $18.11 across 3 prints on 400 shares, for a +$51 win. Read: why a 2x fund can lose money even when your direction is right →

Also on the tape

Smaller pieces that netted into the day: SPCH +$5, BXBL +$0.

Add it up and it was a +$284 day. That puts my running total for this stretch at +$396. Tomorrow I reset and run it back. Read: what 890 trades looked like once I reconstructed the statement →

Keep reading

Next session
1x Short SK Hynix ETF dug a -$347 hole

Day-trading journal for Jul 21, 2026: -$347 on SKHZ, CRNT, SSPC. Running total +$49. -$347

Previous session
Callan JMB led a +$261 day

Day-trading journal for Jul 17, 2026: +$261 on CJMB, SKHZ, SSPC. Running total +$112. +$261

More $SKHU
grinding out a +$106 day on ProShares Ultra SK Hynix

Day-trading journal for Jul 16, 2026: +$106 on SKHU, SPCH. Running total -$150. +$106

Analysis
The quarter that actually worked: April–June 2026

My first quarter of trading, reconstructed from the statement: +$4,323 across 91 trades. Two… +$4,323

Disclaimer: This is a personal trading journal documenting my own trades and opinions. It is not financial or investment advice, and nothing here is a recommendation to buy or sell any security. Day trading, especially in micro-cap and leveraged products, carries a high risk of loss, and most active traders lose money. Figures are reconstructed from my brokerage statement, net of fees. See the full disclaimer.